Recent Advances in Sulfur Dioxide Releasing Nanoplatforms for Cancer Therapy
Pan He,Xiaoyue Ren,Yu Zhang,Bingtong Tang,Chunsheng Xiao
DOI: https://doi.org/10.1016/j.actbio.2023.12.011
IF: 10.633
2023-12-13
Acta Biomaterialia
Abstract:Sulfur dioxide (SO 2 ), long considered to be a harmful atmospheric pollutant, has recently been posited as the fourth gasotransmitter, as it is produced endogenously in mammals and has important pathophysiological effects. The field of tumor therapy has witnessed a paradigm shift with the emergence of SO 2 -based gas therapy. This has been possible because SO 2 is a potent glutathione consumer that can promote the production of reactive oxygen species, eventually leading to oxidative-stress-induced cancer cell death. Nevertheless, this therapeutic gas cannot be directly administrated in gaseous form. Thus, various nano formulations incorporating SO 2 donors or prodrugs capable of storing and releasing SO 2 have been developed in an attempt to achieve active/passive intratumoral accumulation and SO 2 release in the tumor microenvironment. In this review article, the advances over the past decade in nanoplatforms incorporating sulfur SO 2 prodrugs to provide controlled release of SO 2 for cancer therapy are summarized. We first describe the synthesis of polypeptide SO 2 prodrugs to overcome multiple drug resistance that was pioneered by our group, followed by other macromolecular SO 2 prodrug structures that self-assemble into nanoparticles for tumor therapy. Second, we describe nanoplatforms composed of various small-molecule SO 2 donors with endogenous or exogenous stimuli responsiveness, including thiol activated, acid-sensitive, and ultraviolet or near-infrared light-responsive SO 2 donors, which have been used for tumor inhibition. Combinations of SO 2 gas therapy with photodynamic therapy, chemotherapy, photothermal therapy, sonodynamic therapy, and nanocatalytic tumor therapy are also presented. Finally, we discuss the current limitations and challenges and the future outlook for SO 2 -based gas therapy. Statement of Significance : Gas therapy is attracting increasing attention in the scientific community because it is a highly promising strategy against cancer owing to its inherent biosafety and avoidance of drug resistance. Sulfur dioxide (SO 2 ) is recently found to be produced endogenously in mammals with important pathophysiological effects. This review summarizes recent advances in sulfur dioxide (SO 2 ) releasing nanosystems for cancer therapy, including polymeric prodrugs, endogenous or exogenous stimulus-activated SO 2 donors delivered by nanoplatform and combination therapy strategies.
engineering, biomedical,materials science, biomaterials